Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.10.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Cash flows from operating activities:    
Net loss $ (20,163,000) $ (13,526,000)
Adjustments to reconcile net loss to cash used in operating activities:    
Depreciation and amortization 464,000 457,000
Stock option compensation expense 4,573,000 2,735,000
Restricted common stock expense issued to directors and employees 344,000 686,000
Net gain on write off of licensed technology 0 (127,000)
Change in operating assets and liabilities:    
Receivables 60,000 27,000
Prepaid expenses and other current assets 798,000 (712,000)
Other assets 42,000 0
Accounts payable and accrued expenses 3,390,000 (77,000)
Deferred revenue (2,612,000) (302,000)
Net cash used in operating activities (13,104,000) (10,839,000)
Cash flows from investing activities:    
Capital expenditures (6,923,000) (84,000)
Short term investments (69,852,000) 0
Net cash used in investing activities (76,775,000) (84,000)
Cash flows from financing activities:    
Proceeds from exercise of stock options 2,166,000 85,000
Net cash provided by financing activities 2,399,000 85,000
Net decrease in cash, cash equivalents and restricted cash (87,480,000) (10,838,000)
Cash, cash equivalents and restricted cash at beginning of period 138,030,000 69,142,000
Cash, cash equivalents and restricted cash at end of period 50,550,000 58,304,000
Supplemental disclosure:    
Cash and cash equivalents 49,990,000 58,304,000
Restricted cash 560,000 0
Total cash, cash equivalents and restricted cash 50,550,000 58,304,000
Write off of licensed asset and corresponding liability 0 4,000,000
Cash paid for interest 6,000 5,000
Dollar Five Warrant [Member]    
Cash flows from financing activities:    
Proceeds from Warrant Exercises $ 233,000 $ 0